Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

Diseases of autoimmune connective tissues occur in such a way by a preclinical asymptomatic self-immunity. Type I interferons have a crucial role in the progression of established autoimmune diseases. The cellular source and regulation of disease initiation of these cytokines are unclear, but dendritic cells of plasmacytoids have been thought to contribute to the production of excessive interferon type I. Here, we show that in Preclinical autoimmunity and systemic systemic erythematosus established, the dendritic cells of plasmacytoids are not efficient cells, have lost the capacity of the production of cytokine to toll mediation and do not induce the activation of the T cell, independent of The activity of the disease and blood interferon signature. In addition, the dendritic cells of plasmacytoids have an indicative transcriptional signature of cell stress and senescence accompanied by an increase in telomere erosion.

In preclinical self-immunity, we show a marked enrichment of an interferon signature in the skin without infiltrating immune cells, but with interferon-κ production by keratinocytes. In conclusion, non-hematopoietic cellular sources, rather than dendritic cells of plasmacytoids, are responsible for interferon production before clinical self-immunity. The immune system is responsible for identifying malignant cells to eliminate or prevent the propagation of cancer. This involves a complex orchestration of many types of immune cells that together recognize different aspects of the transformation and growth of the tumor. In response, tumors have developed mechanisms to circumvent the immune attack. Type I interferons (IFN-IS) are a class of preflammatory cytokines produced in response to viruses and other environmental stressors.

The IFN-is also emerge as essential pilots of antitumor immunity, stimulating the immune cell capacity for the elimination of tumor cells. However, a more complex role for IFN-is produced, as prolonged stimulation can promote information feedback mechanisms that contribute to immune depletion and other deleterious effects that directly or indirectly or indirectly the cancer cells. to escape immune clearance. We examine the fundamental and opposing functions of the IFN – can modulate the growth of the tumor and the impact of immune function and finally the way these functions can be exploited for the design of new cancer treatments.

The key roles of interferon lambda in human molecular defense against respiratory viral infections

Interferons (IFN) are crucial for the innate immune response. A little over two decades two decades ago, a new type of IFN has been discovered: IFN Lambda (IFN type III). As the other IFN, the IFN type III displays the antiviral activity against a wide variety of infections, they induce the expression of antiviral genes and stimulated by interferon (MX1, OAS, IFITM1) and have activities immunodolory makers that shape adaptive immune responses.

Unlike the other IFN, the IFN type III signal through distinct receptors is limited to a few types of cells, mainly mucous epithelial cells. As a result of their larger and more sustainable production in the nasal and respiratory tissues, they can determine the result of respiratory infections. This examination focuses on the role of IFN-λ in the pathogenesis of respiratory viral infections, with the flu as a great example. The influenza virus is a major public health problem, causing up half a million fatal infections each year. In addition, the virus was the cause of four pandemics in the last century.

Although IFN-λ is increasingly tested in antiviral therapy, they can have a negative influence on the recovery of epithelial tissues and increase the risk of secondary bacterial infections. Therefore, the expression IFN-λ deserves increased monitoring as a key factor in the immune response of the host to infection.

 Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

 

An observational study of the real world of drug use and clinical outcomes of antivirals of direct action and interferon therapy for the treatment of hepatitis C in Taiwan

Objective: In this study, we have studied the use of direct action antivirals (DAAS), medical expenses and clinical outcomes since the initiation of national health insurance coverage in Taiwan.

Methods: It was a retrospective observation study. We have obtained the National Database on Taiwan Health Insurance database in 2017. Patients diagnosed with hepatitis C with at least two visits to physicians or hospitalization were included in the study. Cases have been divided into three groups based on the type of treatment: Traditional treatment (interferon, inf), new drug treatment (DAA) and INF-Experienced (INF followed by DAAS). We compared the distributions of various cases based on individual demographic variables, hospital types and comorbidities. Trends in medical expenses by type of treatment have been estimated. We also analyzed clinical outcomes, including rehospitalization and hepatic function disorders, using a survival analysis method.

Results: Among patients with hepatitis C, the DAA Group had a significantly higher proportion of women, a more meaningful average age and a greater seriousness of the disease than Group INF. The growth rate of medical expenses was significantly lower than the DAA group. In addition, compared to the INF Group, the DAA Group and the infented group have had significantly lower rehospitalization rates and that the DAA group had a significantly lower risk of liver function disorders. In addition, plus a patient received a form of treatment, the lowest was their chance of rehospitalization and hepatic function disorders.

Nori® Bovine 3-Plex ELISA Kits-Interferons

GR228009 96-well
EUR 503

Rat ; Rat embryonic fibroblast

02-705 100ng
EUR 401
Description: The Rat ; Rat embryonic fibroblast is available in Europe and for worldwide shipping via Gentaur.

Rat, Pegylated Rat Leptin Recombinant Protein

PROTP50596-1 20 ug
EUR 317
Description: Mono-Pegylated Leptin Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 147 amino acids and an additional Ala at N-terminus having a molecular mass of 35.6 kDa (with 20 kDa PEG) as determined by mass spectometry. However due to enlarged hydrodymanic volume it runs on the SDS-PAGE as 48 kDa protein and in gel-filtration on Superdex 200 as over 100 kDa protein. Its half-life in circulation after SC injection was over 20 hours. Rat Leptin was purified by proprietary chromatographic techniques according to Salomon et al (2006) Protein Expression and Purification 47, 128–136 and then pegylated._x000D_

Antibody for Rat HO-1 (Rat)

SPC-207D-A680 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 680.

Antibody for Rat HO-1 (Rat)

SPC-207D-A700 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 700.

Antibody for Rat HO-1 (Rat)

SPC-207D-ALP 0.1mg
EUR 372
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Alkaline Phosphatase.

Antibody for Rat HO-1 (Rat)

SPC-207D-APC 0.1mg
EUR 377
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to APC .

Antibody for Rat HO-1 (Rat)

SPC-207D-APCCY7 0.1mg
EUR 450
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to APC/Cy7.

Antibody for Rat HO-1 (Rat)

SPC-207D-BI 0.1mg
EUR 374
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Biotin.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY350 0.1mg
EUR 393
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 350.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY405 0.1mg
EUR 381
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 405.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY488 0.1mg
EUR 371
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 488.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY594 0.1mg
EUR 373
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY633 0.1mg
EUR 368
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 633.

Antibody for Rat HO-1 (Rat)

SPC-207D-FITC 0.1mg
EUR 370
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to FITC.

Antibody for Rat HO-1 (Rat)

SPC-207D-HRP 0.1mg
EUR 366
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to HRP.

Antibody for Rat HO-1 (Rat)

SPC-207D-P594 0.1mg
EUR 385
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to PE/ATTO 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-PCP 0.1mg
EUR 377
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to PerCP.

Antibody for Rat HO-1 (Rat)

SPC-207D-RPE 0.1mg
EUR 375
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to RPE .

Antibody for Rat HO-1 (Rat)

SPC-207D-STR 0.1mg
EUR 376
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Streptavidin.

Antibody for Rat HO-1 (Rat)

SPC-207S 0.012mg
EUR 65
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is unconjugated.

Antibody for Rat HO-1 (Rat)

SPC-207D 0.1mg
EUR 332
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is unconjugated.

Antibody for Rat HO-1 (Rat)

SPC-207D-A390 0.1mg
EUR 379
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 390.

Antibody for Rat HO-1 (Rat)

SPC-207D-A488 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 488.

Antibody for Rat HO-1 (Rat)

SPC-207D-A565 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 565.

Antibody for Rat HO-1 (Rat)

SPC-207D-A594 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-A633 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 633.

Antibody for Rat HO-1 (Rat)

SPC-207D-A655 0.1mg
EUR 378
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 655.

Urocortin, rat

HY-P1296 5mg
EUR 1187

SCF, rat

RC253-12 2ug
EUR 104.38

VEGF165, rat

RC256-18 1mg
EUR 2364.2

CNTF, rat

RC258-19 5ug
EUR 104.38

GDNF, rat

RC258-25 2ug
EUR 104.38

CCL6, rat

RC355-17 2ug
EUR 101.33

CCL11, rat

RC355-22 5ug
EUR 101.33

MIF, rat

RC752-14 50ug
EUR 169.63

EGF, Rat

HY-P7092 50ug
EUR 211

OSM, Rat

HY-P7105 100ug
EUR 1256

CNTF, Rat

HY-P7148 50ug
EUR 497

Leptin, Rat

HY-P7233 50ug
EUR 153

Rat HSV

ERH0317 96Tests
EUR 521

Rat HSV

ERH0318 96Tests
EUR 521

Rat Cardiomyocytes

PC35134 P0 Rat - Whole Heart Dissociated Cells X2
EUR 1419

GDNF (Rat)

PR15008 50 ug
EUR 1277

Leptin-Rat

PR27100 200 ug
EUR 191

Amylin, rat

5-00650 0.4 x 5mg Ask for price

Calcitonin, rat

5-00903 4 x 1mg Ask for price

Galanin, rat

5-01177 4 x 1mg Ask for price

Ghrelin (Rat)

5-01201 4 x 1mg Ask for price

GHRF, rat

5-01204 4 x 1mg Ask for price

Intermedin (rat)

5-01405 4 x 1mg Ask for price

Necrofibrin, rat

5-01585 4 x 5mg Ask for price

PHI, rat

5-01758 4 x 1mg Ask for price

Pneumadin (rat)

5-01780 4 x 5mg Ask for price

Secretin, rat

5-01916 4 x 1mg Ask for price

Urocortin, rat

5-02053 4 x 1mg Ask for price

Rat Serum

abx098267-10ml 10 ml
EUR 272

Rat Fibronectin

7-05200 20µg Ask for price

Rat Fibronectin

7-05201 100µg Ask for price

Rat Fibronectin

7-05202 1mg Ask for price

Pneumadin (rat) )

SP-100080-1 1 mg
EUR 286

Rat(H2b)

QY-E11674 96T
EUR 374

Rat(TRAP)

QY-E11743 96T
EUR 374

CGRP (rat)

B5061-.5 500 µg
EUR 451

CGRP (rat)

B5061-1 1 mg
EUR 814

Ghrelin (rat)

B5120-1 1 mg
EUR 772

Urocortin (rat)

B5146-.5 500 ?g
EUR 337

Urocortin (rat)

B5146-1 1 mg
EUR 487

Urocortin (rat)

B5146-5 5 mg
EUR 1543

Hemopressin (rat)

B5167-1 1 mg
EUR 502

Secretin (rat)

B5232-1 1 mg
EUR 326

Obestatin (rat)

B5306-1 1 mg
EUR 177

Adrenomedullin (rat)

H-2934.0500 0.5mg
EUR 587
Description: Sum Formula: C242H381N77O75S5; CAS# [161383-47-7] net

Adrenomedullin (rat)

H-2934.1000 1.0mg
EUR 961
Description: Sum Formula: C242H381N77O75S5; CAS# [161383-47-7] net

Calcitonin (rat)

H-3072.0001 1.0mg
EUR 236
Description: Sum Formula: C148H228N40O46S3; CAS# [11118-25-5]

Calcitonin (rat)

H-3072.0005 5.0mg
EUR 853
Description: Sum Formula: C148H228N40O46S3; CAS# [11118-25-5]

Urocortin (rat)

H-3362.0500 0.5mg
EUR 273
Description: Sum Formula: C206H338N62O64; CAS# [171543-83-2] net

Urocortin (rat)

H-3362.1000 1.0mg
EUR 418
Description: Sum Formula: C206H338N62O64; CAS# [171543-83-2] net

GRF (rat)

H-5440.0500 0.5mg
EUR 563
Description: Sum Formula: C225H361N77O66S; CAS# [86472-71-1] net

GRF (rat)

H-5440.1000 1.0mg
EUR 1034
Description: Sum Formula: C225H361N77O66S; CAS# [86472-71-1] net

Secretin (rat)

H-5498.0001 1.0mg
EUR 563
Description: Sum Formula: C129H216N42O42; CAS# [121028-49-7]

Secretin (rat)

H-5498.0005 5.0mg
EUR 2159
Description: Sum Formula: C129H216N42O42; CAS# [121028-49-7]

Intermedin (rat)

H-6068.0500 0.5mg
EUR 515
Description: Sum Formula: C226H361N75O64S2; CAS# [1816940-00-7] net

Intermedin (rat)

H-6068.1000 1.0mg
EUR 816
Description: Sum Formula: C226H361N75O64S2; CAS# [1816940-00-7] net

Obestatin (rat)

H-6338.0500 0.5mg
EUR 454
Description: Sum Formula: C114H174N34O31; CAS# [869705-22-6] net

Obestatin (rat)

H-6338.1000 1.0mg
EUR 756
Description: Sum Formula: C114H174N34O31; CAS# [869705-22-6] net

Preptin (rat)

H-6572.0100 0.1mg
EUR 151
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Preptin (rat)

H-6572.0500 0.5mg
EUR 515
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Preptin (rat)

H-6572.1000 1.0mg
EUR 938
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Copeptin (rat)

H-6726.0500 0.5mg
EUR 393
Description: Sum Formula: C183H307N57O61; CAS# [86280-64-0] net

Copeptin (rat)

H-6726.1000 1.0mg
EUR 696
Description: Sum Formula: C183H307N57O61; CAS# [86280-64-0] net

Alarin (rat)

H-6762.0500 0.5mg
EUR 231
Description: Sum Formula: C119H199N45O35; CAS# [909409-88-7] net

Alarin (rat)

H-6762.1000 1.0mg
EUR 360
Description: Sum Formula: C119H199N45O35; CAS# [909409-88-7] net

Rat IgM

31C-CH1213 1 mg
EUR 377
Description: Purified Rat IgM

Rat IgG

M1101-100
EUR 153

Rat IgG

M1101-1000
EUR 370

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-002 2ug
EUR 293

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-010 10ug
EUR 408

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-101 1mg
EUR 6935

Rat anti Mouse(Rat) TNFRSF1A monoclonal antibody

CABT-L335 500ug
EUR 819

Liver Dissociation System 4 (Hepatocytes, rat), Rat

4-20304 ea Ask for price

CST3 Rat, Cystatin C Rat Recombinant Protein, sf9

PROTP14841-1 Regular: 10ug
EUR 317
Description: CST3 Rat Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 128 amino acids (21-140a.a.) and having a molecular mass of 14.3kDa (Molecular size on SDS-PAGE will appear at approximately 13.5-18kDa)._x000D_ CST3 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques

Pancreas Dissociation System 6 (Acinar, rat parotid), Rat

4-20376 ea Ask for price

Rat IgG2a (FITC) / Rat IgG2a (RPE) Isotype Control

abx405004-100tests 100 tests
EUR 634

Rat Thrombopoietin (Thpo)

1-CSB-RP076444r
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Thrombopoietin(Thpo),partial expressed in E.coli

Rat Haptoglobin (Hp)

1-CSB-RP170694r
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Haptoglobin(Hp),partial expressed in E.coli

Rat Hemopexin (Hpx)

1-CSB-YP010723RA
  • EUR 504.00
  • EUR 265.00
  • EUR 1832.00
  • EUR 763.00
  • EUR 1216.00
  • EUR 334.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Hemopexin(Hpx) expressed in Yeast

Rat Matrilysin (Mmp7)

1-CSB-YP014677RA
  • EUR 504.00
  • EUR 265.00
  • EUR 1832.00
  • EUR 763.00
  • EUR 1216.00
  • EUR 334.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Matrilysin(Mmp7) expressed in Yeast

Rat Neogenin (Neo1)

1-CSB-YP015712RA
  • EUR 586.00
  • EUR 299.00
  • EUR 2172.00
  • EUR 900.00
  • EUR 1442.00
  • EUR 382.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Neogenin(Neo1),partial expressed in Yeast

Rat Regucalcin (Rgn)

1-CSB-YP019630RA
  • EUR 504.00
  • EUR 265.00
  • EUR 1832.00
  • EUR 763.00
  • EUR 1216.00
  • EUR 334.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Regucalcin(Rgn) expressed in Yeast

Rat Sortilin (Sort1)

1-CSB-YP022412RA
  • EUR 504.00
  • EUR 265.00
  • EUR 1832.00
  • EUR 763.00
  • EUR 1216.00
  • EUR 334.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Sortilin(Sort1),partial expressed in Yeast

Rat Podocalyxin (Podxl)

1-CSB-YP893876RA
  • EUR 504.00
  • EUR 265.00
  • EUR 1832.00
  • EUR 763.00
  • EUR 1216.00
  • EUR 334.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Podocalyxin(Podxl),partial expressed in Yeast

Rat Serotransferrin (Tf)

1-CSB-YP023412RA
  • EUR 679.00
  • EUR 335.00
  • EUR 2172.00
  • EUR 1051.00
  • EUR 1442.00
  • EUR 435.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Serotransferrin(Tf) expressed in Yeast

Rat Sclerostin (Sost)

1-CSB-EP859165RA
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Sclerostin(Sost) expressed in E.coli

Rat Lumican (Lum)

1-CSB-MP013234RA
  • EUR 293.00
  • EUR 963.00
  • EUR 409.00
  • EUR 717.00
  • 100ug
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Rat Lumican(Lum) expressed in Mammalian cell

Rat Sortilin (Sort1)

1-CSB-EP022412RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Sortilin(Sort1),partial expressed in E.coli

Rat Sortilin (Sort1)

1-CSB-EP022412RAa0
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Sortilin(Sort1),partial expressed in E.coli

Rat Serotransferrin (Tf)

1-CSB-EP023412RA
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Serotransferrin(Tf) expressed in E.coli

Rat Thyroglobulin (Tg)

1-CSB-EP023442RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Thyroglobulin(Tg),partial expressed in E.coli

Rat Tryptase (Tpsab1)

1-CSB-EP024127RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Tryptase(Tpsab1) expressed in E.coli

Rat Artemin (Artn)

1-CSB-EP002160RA
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Artemin(Artn) expressed in E.coli

Rat Osteocalcin (Bglap)

1-CSB-EP002682RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Osteocalcin(Bglap) expressed in E.coli

Rat Calmodulin (Calm1)

1-CSB-EP004445RA
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Calmodulin(Calm1) expressed in E.coli

Rat Calmodulin (Calm1)

1-CSB-EP004445RAb1
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Calmodulin(Calm1) expressed in E.coli

Rat Hemopexin (Hpx)

1-CSB-EP010723RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Hemopexin(Hpx) expressed in E.coli

Rat Lumican (Lum)

1-CSB-EP013234RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Lumican(Lum) expressed in E.coli

Rat Matrilysin (Mmp7)

1-CSB-EP014677RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Matrilysin(Mmp7) expressed in E.coli

Rat Osteocrin (Ostn)

1-CSB-EP017269RA
  • EUR 505.00
  • EUR 265.00
  • EUR 1827.00
  • EUR 766.00
  • EUR 1218.00
  • EUR 335.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Osteocrin(Ostn),partial expressed in E.coli

Rat Regucalcin (Rgn)

1-CSB-EP019630RA
  • EUR 611.00
  • EUR 309.00
  • EUR 1827.00
  • EUR 939.00
  • EUR 1218.00
  • EUR 397.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Rat Regucalcin(Rgn) expressed in E.coli

Rat IGF-I

RM001 1 mg
EUR 1088

Rat IGF-I

RU020 20 µg
EUR 253

Rat IGF-I

RU100 100 µg
EUR 346

Rat Growth Hormone

GHCM001 1 mg
EUR 624

Rat Growth Hormone

GHCM005 5 mg
EUR 161

Rat Growth Hormone

GHCU020 20 µg
EUR 253

Rat Growth Hormone

GHCU100 100 µg
EUR 346

Neuromedin U, rat

HY-P1238 5mg
EUR 991

Amylin, amide, rat

HY-P1464 1mg
EUR 418

Pancreatic Polypeptide, rat

HY-P1532 5mg
EUR 1542

Oncostatin M, rat

RC254-19 2ug
EUR 104.38

FGF-9, rat

RC255-20 5ug
EUR 104.38

FGF-10, rat

RC255-21 5ug
EUR 104.38

FGF-18, rat

RC255-29 5ug
EUR 104.38

FGF-21, rat

RC255-32 5ug
EUR 104.38

IGF-1, rat

RC256-12 50ug
EUR 152.66

HB-EGF, rat

RC256-25 2ug
EUR 104.38

GMF beta, rat

RC258-18 2ug
EUR 101.33

BD-1, rat

RC260-12 5ug
EUR 104.38

BD-3, rat

RC260-14 5ug
EUR 104.38

BD-4, rat

RC260-15 5ug
EUR 104.38

LIX, CXCL5, rat

RC352-16 5ug
EUR 101.33

Fractalkine, CX3CL1, rat

RC354-12 5ug
EUR 104.38

MDC, CCL22, rat

RC355-33 5ug
EUR 104.38

CONCLUSIONS: In conclusion, our results have confirmed that DAAS insurance coverage has led to better clinical results than INF, which can reduce the increases in medical expenses and the risk of rehospital and functional disorders hepatic. What we know about this subject, interferon for hepatitis C has a low efficiency with serious side effects, while the effectiveness of new oral drugs (direct action antivirals, DAAS) is high. DAAs have been approved for a Taiwan registration in December 2013 and have been covered by national health insurance since January 2017. Little things are known about the proofs of the real world related to the DAA following the coverage of DAA In Taiwan, including the use of drugs, expenses and expenses. security.

Leave A Comment